{"schema_version":"secwatch.filing_event.v1","accession":"0000899923-23-000102","form_type":"8-K","ticker":"MYGN","cik":"0000899923","company_name":"MYRIAD GENETICS INC","filed_at":"2023-11-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.342929+00:00","generated_at":"2026-06-08T08:22:05.111252+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Myriad Genetics prices upsized 6.47M-share offering at $17.00 for ~$110M gross","bullets":["Offering of 6,470,588 shares upsized; priced at $17.00/share; expected gross proceeds ~$110M.","Underwriters granted 30-day option for up to 970,588 additional shares at same price.","Net proceeds: ~$40M to repay asset-based revolving credit facility; ~$57.5M to settle securities class action (In re Myriad Genetics).","Remainder for working capital and general corporate purposes; closing expected Nov 13, 2023.","Goldman Sachs, Morgan Stanley, and Wells Fargo acting as joint book-running managers."],"urls":{"canonical":"https://secwatch.observer/filing/0000899923-23-000102","json":"https://secwatch.observer/filing/0000899923-23-000102.json","markdown":"https://secwatch.observer/filing/0000899923-23-000102.md","text":"https://secwatch.observer/filing/0000899923-23-000102.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/899923/000089992323000102/0000899923-23-000102-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/899923/000089992323000102/mygn-20231108.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T08:22:05.111252+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}